Mefenorex

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Mefenorex
Mefenorex.svg
Systematic (IUPAC) name
3-chloro-N-(1-methyl-2-phenylethyl)propan-1-amine
Clinical data
Identifiers
17243-57-1 YesY
A08AA09
PubChem CID 21777
ChemSpider 20467 YesY
UNII K98M4N387W YesY
KEGG D07891 YesY
Chemical data
Formula C12H18ClN
211.731
 YesY (what is this?)  (verify)

Mefenorex (Rondimen, Pondinil, Anexate) is a stimulant drug which was used as an appetite suppressant. It is an amphetamine derivative which was developed in the 1970s and used for the treatment of obesity.[1][2] Mefenorex produces amphetamine as a metabolite,[3] and has been withdrawn in many countries despite having only mild stimulant effects and relatively little abuse potential.[4]

References[edit]

  1. ^ Vincendeau MJ. A new regulator of appetite: mefenorex. (French). Bordeaux Medical. 1970 Jul-Aug;3(7):1951-3.
  2. ^ Beyer G, Huth K, Muller GM, Niemoller H, Raisp I, Vorberg G. The treatment of obesity with the appetite curbing agent Mefenorex. (German). Die Medizinische Welt. 1980 Feb;31(8):306-9.
  3. ^ Rendic S, Slavica M, Medic-Saric M. Urinary excretion and metabolism of orally administered mefenorex. European Journal of Drug Metabolism and Pharmacokinetics. 1994 Apr-Jun;19(2):107-17.
  4. ^ Engel J, Kristen G, Schaefer A, von Schlichtegroll A. Mefenorex (Rondimen). Drug and Alcohol Dependence. 1986 Jun;17(2-3):229-34.